Akoya Biosciences, Inc. Quarterly Cost of Revenue in USD from Q1 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Akoya Biosciences, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2020 to Q2 2024.
  • Akoya Biosciences, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $9.78M, a 14.3% decline year-over-year.
  • Akoya Biosciences, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $39.6M, a 5.09% increase year-over-year.
  • Akoya Biosciences, Inc. annual Cost of Revenue for 2023 was $40.3M, a 28.2% increase from 2022.
  • Akoya Biosciences, Inc. annual Cost of Revenue for 2022 was $31.5M, a 52% increase from 2021.
  • Akoya Biosciences, Inc. annual Cost of Revenue for 2021 was $20.7M, a 25.2% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $39.6M $9.78M -$1.63M -14.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $41.2M $9.97M +$854K +9.37% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $40.3M $9.87M +$694K +7.57% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $39.6M $9.94M +$1.99M +25.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $37.6M $11.4M +$3.85M +51% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $33.8M $9.12M +$2.32M +34.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 $31.5M $9.17M +$3.24M +54.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $28.2M $7.95M +$2.92M +58.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $25.3M $7.55M +$2.62M +53% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $22.7M $6.8M +$1.99M +41.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $20.7M $5.93M +$932K +18.6% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-07
Q3 2021 $19.8M $5.02M +$1.1M +28.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $18.7M $4.94M +$1.65M +50.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $17M $4.81M +$482K +11.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $16.5M $5M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-15
Q3 2020 $3.92M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $3.29M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 $4.33M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.